Literature DB >> 20230372

Lipophilic mediated assays for beta-hematin inhibitors.

Melissa D Carter1, Vanessa V Phelan, Rebecca D Sandlin, Brian O Bachmann, David W Wright.   

Abstract

The growing drug resistance of Plasmodia spp. to current antimalarial agents in the quinine and artemisinin families further asserts the need for novel drug classes to combat malaria infection. One approach to the discovery of new antimalarials is the screening of natural product extracts for activity against the formation of hemozoin, a biomineral essential to parasite survival. By mimicking the in vivo lipid-water interface at which native hemozoin is found, hemozoin can be synthesized outside the parasite. In this work, a variety of lipophilic mediators was used to determine the optimal platform for in vitro hemozoin formation and then tested for efficacy in preliminary screens containing crude natural product extracts. The complete optimization and validation of a NP-40 detergent-mediated assay provide a screening template with an expedited 4-hour incubation time and identical IC50 values to those measured from the parasite's native lipid component.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230372      PMCID: PMC2901836          DOI: 10.2174/138620710790980496

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  32 in total

1.  Metalloporphyrin probes for antimalarial drug action.

Authors:  James Ziegler; Lisa Pasierb; Kelly A Cole; David W Wright
Journal:  J Inorg Biochem       Date:  2003-09-01       Impact factor: 4.155

2.  The structure of malaria pigment beta-haematin.

Authors:  S Pagola; P W Stephens; D S Bohle; A D Kosar; S K Madsen
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

3.  Three-dimensional crystals of membrane proteins: bacteriorhodopsin.

Authors:  H Michel; D Oesterhelt
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

4.  Three-dimensional crystals of a membrane protein complex. The photosynthetic reaction centre from Rhodopseudomonas viridis.

Authors:  H Michel
Journal:  J Mol Biol       Date:  1982-07-05       Impact factor: 5.469

Review 5.  Heme Aggregation inhibitors: antimalarial drugs targeting an essential biomineralization process.

Authors:  J Ziegler; R Linck; D W Wright
Journal:  Curr Med Chem       Date:  2001-02       Impact factor: 4.530

6.  Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs.

Authors:  S Parapini; N Basilico; E Pasini; T J Egan; P Olliaro; D Taramelli; D Monti
Journal:  Exp Parasitol       Date:  2000-12       Impact factor: 2.011

Review 7.  Qinghaosu (artemisinin): the price of success.

Authors:  N J White
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

8.  Inhibition of heme crystal growth by antimalarials and other compounds: implications for drug discovery.

Authors:  Curtis Robert Chong; David Joseph Sullivan
Journal:  Biochem Pharmacol       Date:  2003-12-01       Impact factor: 5.858

9.  Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials.

Authors:  Paul M O'Neill; Amira Mukhtar; Paul A Stocks; Laura E Randle; Stephen Hindley; Stephen A Ward; Richard C Storr; Jamie F Bickley; Ian A O'Neil; James L Maggs; Ruth H Hughes; Peter A Winstanley; Patrick G Bray; B Kevin Park
Journal:  J Med Chem       Date:  2003-11-06       Impact factor: 7.446

10.  Three-dimensional crystals of an integral membrane protein: an initial x-ray analysis.

Authors:  R M Garavito; J P Rosenbusch
Journal:  J Cell Biol       Date:  1980-07       Impact factor: 10.539

View more
  22 in total

1.  Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization.

Authors:  Rebecca D Sandlin; Melissa D Carter; Patricia J Lee; Jennifer M Auschwitz; Susan E Leed; Jacob D Johnson; David W Wright
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Identification and Mechanistic Evaluation of Hemozoin-Inhibiting Triarylimidazoles Active against Plasmodium falciparum.

Authors:  Kathryn J Wicht; Jill M Combrinck; Peter J Smith; Roger Hunter; Timothy J Egan
Journal:  ACS Med Chem Lett       Date:  2017-01-24       Impact factor: 4.345

3.  Insights into structural and physicochemical properties required for β-hematin inhibition of privileged triarylimidazoles.

Authors:  Clinton G L Veale; Janeeka Jayram; Shivani Naidoo; Dustin Laming; Tarryn Swart; Tania Olivier; Matthew P Akerman; Katherine A de Villiers; Heinrich C Hoppe; Vineet Jeena
Journal:  RSC Med Chem       Date:  2019-12-16

4.  High-Throughput Screening and Prediction Model Building for Novel Hemozoin Inhibitors Using Physicochemical Properties.

Authors:  Nguyen Tien Huy; Pham Lan Chi; Jun Nagai; Tran Ngoc Dang; Evaristus Chibunna Mbanefo; Ali Mahmoud Ahmed; Nguyen Phuoc Long; Le Thi Bich Thoa; Le Phi Hung; Afaf Titouna; Kaeko Kamei; Hiroshi Ueda; Kenji Hirayama
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

5.  Interrogating alkyl and arylalkylpolyamino (bis)urea and (bis)thiourea isosteres as potent antimalarial chemotypes against multiple lifecycle forms of Plasmodium falciparum parasites.

Authors:  Bianca K Verlinden; Marna de Beer; Boobalan Pachaiyappan; Ethan Besaans; Warren A Andayi; Janette Reader; Jandeli Niemand; Riette van Biljon; Kiplin Guy; Timothy Egan; Patrick M Woster; Lyn-Marie Birkholtz
Journal:  Bioorg Med Chem       Date:  2015-01-28       Impact factor: 3.641

6.  The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization.

Authors:  Sharné-Maré Fitzroy; Johandie Gildenhuys; Tania Olivier; Ndivhuwo Olga Tshililo; David Kuter; Katherine Allison de Villiers
Journal:  Langmuir       Date:  2017-07-19       Impact factor: 3.882

7.  Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains.

Authors:  Monika Chugh; Christian Scheurer; Sibylle Sax; Elizabeth Bilsland; Donelly A van Schalkwyk; Kathryn J Wicht; Natalie Hofmann; Anil Sharma; Sridevi Bashyam; Shivendra Singh; Stephen G Oliver; Timothy J Egan; Pawan Malhotra; Colin J Sutherland; Hans-Peter Beck; Sergio Wittlin; Thomas Spangenberg; Xavier C Ding
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

Review 8.  Hemozoin and antimalarial drug discovery.

Authors:  Kim Y Fong; David W Wright
Journal:  Future Med Chem       Date:  2013-08       Impact factor: 3.808

9.  Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.

Authors:  Kathryn J Wicht; Jill M Combrinck; Peter J Smith; Roger Hunter; Timothy J Egan
Journal:  J Med Chem       Date:  2016-06-24       Impact factor: 7.446

10.  Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites.

Authors:  Fabrizio P L'abbate; Ronel Müller; Roxanne Openshaw; Jill M Combrinck; Katherine A de Villiers; Roger Hunter; Timothy J Egan
Journal:  Eur J Med Chem       Date:  2018-09-28       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.